Combined hepatocellular cholangiocarcinoma: Controversies to be addressed
Open Access
- 1 January 2016
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 22 (18), 4459-4465
- https://doi.org/10.3748/wjg.v22.i18.4459
Abstract
Combined hepatocellular cholangiocarcinoma (CHC) accounts for 0.4%-14.2% of primary liver cancer cases and possesses pathological features of both hepatocellular carcinoma and cholangiocarcinoma. Since this disease was first described and classified in 1949, the classification of CHC has continuously evolved. The latest definition and classification of CHC by the World Health Organization is based on the speculation that CHC arises from hepatic progenitor cells. However, there is no evidence demonstrating the common origin of different components of CHC. Furthermore, the definition of CHC subtypes is still ambiguous and the identification of CHC subtype when a single tumor contains many components has remained unresolved. In addition, there is no summary on the newly recognized histopathology features or the contribution of CHC components to prognosis and outcome of this disease. Here we provide a review of the current literature to address these questions.Keywords
This publication has 55 references indexed in Scilit:
- Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-CholangiocarcinomaPLOS ONE, 2013
- The Diagnostic Conundrum and Liver Transplantation Outcome for Combined Hepatocellular‐CholangiocarcinomaAmerican Journal of Transplantation, 2010
- A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic ChemotherapyCancer Research and Treatment, 2010
- Recurrent hepatocellular carcinoma is a problem we need to tackleLiver Transplantation, 2007
- Recurrence Patterns of Combined Hepatocellular-Cholangiocarcinoma on Enhanced Computed TomographyJournal of Computer Assisted Tomography, 2007
- Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomasJournal of Hepatology, 2004
- Primary liver carcinoma of intermediate (hepatocyte–cholangiocyte) phenotypeJournal of Hepatology, 2004
- A Successful Resection and Long-Term Survival of a Patient with Intrahepatic Recurrences of Combined Hepatocellular-Cholangiocarcinoma: Report of a CaseSurgery Today, 2002
- Combined Hepatocellular-CholangiocarcinomaActa Cytologica, 1997
- Mutational Analysis of the p53 and K‐ras Genes and Allelotype Study of the Rb‐1 Gene for Investigating the Pathogenesis of Combined Hepatocellular‐Cholangiocellular CarcinomasJapanese Journal of Cancer Research, 1996